VIRIOS THERAPEUTICS INC (VIRI)       0.325  +0.01 (+3.17%)

0.325  +0.01 (+3.17%)

US92829J1043 - Common Stock - After market: 0.3215 0 (-1.08%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.28 -0.50 0.2243.98% Q2 2022 -0.44 -0.52 0.0814.58% Q1 2022 -0.48 -0.55 0.0712.04% Q4 2021 -0.54 -0.69 0.1521.57% Q3 2021 -0.49 -0.71 0.2230.88% Q2 2021 -0.51 -0.57 0.0610.71%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -1.20 -2.09 42.44%Q4 2022 -0.16 -0.54 70.72%FY 2023 -0.74 -1.20 38.14%Q1 2023 -0.16 -0.48 66.00%Q2 2023 -0.10 -0.44 76.82%Q3 2023 -0.12 -0.28 56.29%Q4 2023 -0.13 -0.16 16.13%FY 2024 -0.60 -0.74 19.86%FY 2025 -0.63 -0.60 -5.98%FY 2026 -0.89 -0.63 -40.32%FY 2027 -1.24 -0.89 -40.23%FY 2028 -1.73 -1.24 -39.34%FY 2029 -2.38 -1.73 -37.06%FY 2030 -2.98 -2.38 -25.32%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 % Q2 2022 % Q1 2022 % Q4 2021 % Q3 2021 % Q2 2021 %
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 %Q4 2022 %FY 2023 %Q1 2023 %Q2 2023 %Q3 2023 %Q4 2023 %FY 2024 %FY 2025 %FY 2026 %FY 2027 %FY 2028 %FY 2029 %FY 2030 %